The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Three-arm randomized trial of sodium alginate, orally administered mucoprotective agent, for preventing radiation esophagitis in pts with locally advanced non-small-cell lung cancer (LA-NSCLC) receiving concurrent chemoradiotherapy (CRT): Okayama Lung Cancer Study Group 1401.
 
Katsuyuki Hotta
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma
 
Kiichiro Ninomiya
Honoraria - Lilly Japan
 
Isao Oze
No Relationships to Disclose
 
Akihiro Bessho
No Relationships to Disclose
 
Toshi Murakami
No Relationships to Disclose
 
Naoyuki Sone
No Relationships to Disclose
 
Shingo Harita
No Relationships to Disclose
 
Naoyuki Nogami
No Relationships to Disclose
 
Shoichi Kuyama
Honoraria - Astellas Pharma; Boehringer Ingelheim; Chugai Pharma; Kyorin; Novartis; Pfizer
 
Mitsune Tanimoto
No Relationships to Disclose
 
Katsuyuki Kiura
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Novartis; Pfizer
Research Funding - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Novartis; Pfizer (Inst)